Antigen discovery

Discovering new antigens for vaccine development

Vaccine development requires the identification of antigens, and often only a combination of antigens provides optimal protective efficacy (e.g. acellular pertussis vaccine).

AVRA will exploit internationally-renowned Australian research in virology, bacteriology and immunology, and deploy novel technologies for the identification and assessment of antigens from viruses and antibiotic resistant bacteria.